BTIG announced today that it will host its annual MedTech, Digital Health, Life Science and Diagnostic Tools Conference on Tuesday, February 11 through Wednesday, February 12, 2025. The firm expects ...

Concepts Inc (NASDAQ:TMCI) received an upgrade from BTIG, with analyst Ryan Zimmerman changing the stock rating from Neutral to Buy and setting a new price target of $16.00. This upgrade comes after a ...

BTIG Research has recently reduced MGM Resorts International (MGM) stock to Neutral rating, as announced on February 3, 2025, according to Finviz. Earlier, on July 3, 2024, BTIG Research had initiated ...

BTIG analyst Ryan Zimmerman upgraded Treace Medical (TMCI) to Buy from Neutral with a $16 price target The company has pivoted away from ...

ROCKAWAY, N.J., Feb. 04, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness ...

Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus", "SLP"), a leading provider of cheminformatics, biosimulation, ...

BTIG analyst David Larsen adjusted the firm's stance on IQVIA Holdings (NYSE:IQV), moving from a Buy rating to Neutral. The $36.5 billion market cap company, currently trading near its 52-week low at ...

Research analysts at BTIG Research reduced their Q4 2025 earnings estimates for shares of D.R. Horton in a research note ...

BTIG is a leading global financial services firm specializing in investment banking, institutional trading, research, and ...

Physicians also expect greater use of Johnson & Johnson’s Varipulse system over the next two years despite the company’s ...

周二，BTIG分析师Ryan Zimmerman将Treace Medical Concepts Inc (NASDAQ: TMCI )的股票评级从中性上调至买入，并设定新目标价16.00美元。此次上调是在公司战略调整和市场地位重新评估后做出的。根据 InvestingPro 数据显示，该股在过去六个月内涨幅达47%，但仍低于52周高点15.98美元。

周一，BTIG分析师Mark Massaro宣布将IDEXX Laboratories (NASDAQ:IDXX)的目标股价从500美元上调至530美元，同时维持对该股票的买入评级。此次调整是在IDEXX第四季度业绩超出收入和盈利预期后做出的。目前，该公司市值为385亿美元，股价为469.04美元，InvestingPro分析显示该股票的交易价格高于其公允价值。 尽管宠物就诊量下降，IDEXX L ...